試す 金 - 無料
Remote diagnostics greatly influence the accessibility and quality of healthcare
Bio Spectrum
|BioSpectrum Indian Feb 2025
The healthcare industry has undergone tremendous change thanks to remote diagnostics. These enable healthcare providers to provide diagnostic services to patients in even the most remote locations by utilising digital tools and telecommunication technologies. The accessibility and quality of healthcare will be significantly impacted by remote diagnostics, but to assure universal use, a few problems must be resolved.
-
T The diagnostics industry in India is growing rapidly, driven by growing healthcare awareness, an increasing prevalence of chronic diseases and lifestyle disorders, and advancements in technology. It encompasses pathology labs, imaging centres, and specialised diagnostic services - all of which contribute significantly to the healthcare sector.
Key trends in this area include the adoption of digital diagnostics, AI-powered tools, point-ofcare testing, and a surge in home-based diagnostic services and telemedicine. Despite regulatory hurdles and infrastructure gaps, the Indian diagnostics market is poised for substantial growth, improving accessibility and quality of healthcare across the country.
Recent technology developments, particularly in remote diagnostics, have significantly altered the healthcare landscape. These allow medical professionals to reach patients in even the most remote areas using digital tools and telecommunication technologies to deliver diagnostic services. Remote diagnostics will have a significant impact on healthcare accessibility and quality, but there are certain issues that need to be addressed to ensure widespread adoption.
Impact of Remote Diagnostics on Healthcare Accessibility
One of the most significant benefits of remote diagnostics is improving accessibility of healthcare services to the underserved and vulnerable populations such as elderly people, immobile, disabled individuals, and residents of less economically developed areas. In many rural and remote regions of India, people have limited access to healthcare and specialised doctors. Distant diagnostics bridges the gap by providing patients with timely diagnostic services, eliminating the need to travel long distances in emergent situations.
このストーリーは、Bio Spectrum の BioSpectrum Indian Feb 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Bio Spectrum からのその他のストーリー
Bio Spectrum
Biotium's new cell barcoding kit streamlines flow cytometry with single-tube multiplexing
Biotium, a leading provider of fluorescent reagents and kits for life science research, has announced the release of the ViaPlex 2-Color Cell Barcoding Kit.
1 min
May 2026
Bio Spectrum
NATHEALTH names Dr Sangita Reddy as new President
NATHEALTH, an apex body representing the Indian healthcare industry, has announced Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, as its new President for FY 2026-2027.
1 min
May 2026
Bio Spectrum
Rs 4.51 Lakh Crore Health Push: How State Budgets Are Powering India's Next Healthcare Leap
In recent years, state health budgets have transformed from simple financial documents into strategic instruments for improving healthcare outcomes.
7 mins
May 2026
Bio Spectrum
WHO lays focus on simulation exercises to strengthen health emergency readiness
To support countries to prepare more systematically against emergencies, WHO has recently released new global guidance which enables countries to move beyond oneoff emergency drills and establish National Health Simulation Exercise Programmes (NHSEP).
1 min
May 2026
Bio Spectrum
Akrivia Biosciences decodes breast cancer genomic heterogeneity
Akrivia Biosciences, a cancer genomics startup based in London and Mumbai, has announced a foundational scientific breakthrough that uncovers hidden organisation of cancer genomes, successfully decoding breast cancer genomic heterogeneity, a major bottleneck that has historically hindered the comprehensive understanding of tumour biology in patients.
1 min
May 2026
Bio Spectrum
Integrating AI for Tech-driven Ayurveda
A promising trend emerging in 2026 is the integration of artificial intelligence (AI) into ayurveda, to not only make ayurveda more accessible and scalable but to also create opportunities to back up ayurveda with science and technology.
2 mins
May 2026
Bio Spectrum
ASPIRE BIONEST signs MoU with Indian Immunologicals to advance One Health Innovation
ASPIRE BIONEST, a life sciences incubation centre at the University of Hyderabad, has signed a strategic Memorandum of Understanding (MoU) with Indian Immunologicals Ltd. (IIL), a leading vaccine-focused biotechnology company, to advance innovation under the One Health framework.
1 min
May 2026
Bio Spectrum
MSD India and Smile Foundation award 50 scholarships to aspiring pharmacy students
MSD (known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada) in India has announced the awarding of scholarships to 50 students under its corporate social responsibility initiative 'Scholarship for Daughters' programme, a merit-based initiative aimed at supporting young women from underserved communities to pursue a Bachelor of Pharmacy degree at select accredited pharmacy colleges across India.
1 min
May 2026
Bio Spectrum
Thermo Fisher launches integrated platform to accelerate biologics development
Thermo Fisher Scientific Inc. has announced a next-generation, integrated cell line development platform that enables biologics developers to accelerate time to clinic while maintaining regulatory confidence and commercial scalability.
1 min
May 2026
Bio Spectrum
Eurofins Viracor unveils ExPECT anti-CD19 (obe-cel) CAR T-cell assay
Eurofins Viracor, a leader in advanced clinical diagnostics, has announced the launch of the ExPECT anti-CD19 (obe-cel) CAR T-cell assay, a cutting-edge solution designed to help clinicians monitor CAR T-cell therapy performance with validated precision and a quick turn-around-time for results.
1 min
May 2026
Listen
Translate
Change font size
